| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | -0.022 | 0.9 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.023 | 0.9 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |